Frequency Therapeutics, Inc. (33)

Browse by Contract Category

Contracts

Sublease Agreement, dated July 8, 2022, by and between Frequency Therapeutics, Inc. and Saliogen Therapeutics, Inc (Filed With SEC on July 12, 2022)
Employment Agreement, dated as of November 25, 2020, by and between Frequency Therapeutics, Inc. and Quentin McCubbin (Filed With SEC on May 4, 2022)
Letter Agreement, dated April 15, 2022, by and between Frequency Therapeutics, Inc. and Wendy Arnold (Filed With SEC on April 15, 2022)
Exclusive Patent License Agreement, dated as of December 13, 2016, as amended, between Massachusetts Institute of Technology and Frequency Therapeutics, Inc (Filed With SEC on March 15, 2022)
Equity Distribution Agreement, dated as of December 10, 2021, between Frequency Therapeutics, Inc. and Oppenheimer & Co. Inc (Filed With SEC on December 10, 2021)
Form of Indemnification Agreement for Directors and Officers (Filed With SEC on September 23, 2019)
Letter Agreement, dated April 15, 2022, by and between Frequency Therapeutics, Inc. and Richard Mitrano (Filed With SEC on April 15, 2022)
Separation Agreement, dated as of March 31, 2022, by and between Frequency Therapeutics, Inc. and Peter P. Pfreundschuh (Filed With SEC on March 31, 2022)
Employment Agreement, effective February 3, 2020, by and between Frequency Therapeutics, Inc. and Wendy S. Arnold (Filed With SEC on March 29, 2021)
Agreement for Termination of Lease and Voluntary Surrender of Premises, dated December 11, 2020, by and between Frequency Therapeutics, Inc. and ARE-MA-Region No. 20, LLC (Filed With SEC on December 16, 2020)
Loan and Security Agreement, dated December 11, 2020, by and between Frequency Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on December 15, 2020)
Employment Agreement, effective December 1, 2020, by and between Frequency Therapeutics, Inc. and Peter P. Pfreundschuh (Filed With SEC on December 1, 2020)
Registration Rights Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein (Filed With SEC on July 21, 2020)
Securities Purchase Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein (Filed With SEC on July 21, 2020)
Lease Agreement, dated as of August 24, 2016, as amended, between ARE-MA Region No. 20 and Frequency Therapeutics, Inc (Filed With SEC on March 26, 2020)
Indenture of Lease, effective as of January 7, 2020 between HCP/KING 75 Hayden LLC and Frequency Therapeutics, Inc (Filed With SEC on March 26, 2020)
Description of Frequency Therapeutics, Inc. Securities (Filed With SEC on March 26, 2020)
Form of Specimen Common Stock Certificate (Filed With SEC on September 23, 2019)
Employment Agreement, dated as of September 19, 2019, between Carl P. LeBel and the Registrant (Filed With SEC on September 23, 2019)
2019 Incentive Award Plan and form of option agreements thereunder (Filed With SEC on September 23, 2019)
Non-Employee Director Compensation Program (Filed With SEC on September 23, 2019)
Lease Agreement, effective as of August 1, 2019 between the University of Connecticut and the Registrant (Filed With SEC on September 23, 2019)
Second Amended and Restated Executive Employment Agreement, dated as of September 20, 2019, between David L. Lucchino and the Registrant (Filed With SEC on September 23, 2019)
Amended and Restated Employment Agreement, dated as of September 20, 2019, between Christopher R. Loose and the Registrant (Filed With SEC on September 23, 2019)
2019 Employee Stock Purchase Plan (Filed With SEC on September 23, 2019)
Form of Underwriting Agreement (Filed With SEC on September 23, 2019)
Lease Agreement, dated as of August 24, 2016, between ARE-MA Region No. 20 and the Registrant (Filed With SEC on September 6, 2019)
Second Amended and Restated Investors Rights Agreement, dated as of July 17, 2019, by and among the Registrant and the investors party thereto (Filed With SEC on September 6, 2019)
2014 Stock Incentive Plan, as amended, and form of option agreements thereunder (Filed With SEC on September 6, 2019)
Form of Founder Restricted Stock Agreement (Filed With SEC on September 6, 2019)
Exclusive Patent License Agreement, dated as of December 13, 2016, as amended, between Massachusetts Institute of Technology and the Registrant (Filed With SEC on September 6, 2019)
Non-Exclusive Patent License Agreement, dated as of February 7, 2019, between Massachusetts Eye and Ear Infirmary and the Registrant (Filed With SEC on September 6, 2019)
License and Collaboration Agreement, dated as of July 16, 2019, between Astellas Pharma, Inc. and the Registrant (Filed With SEC on September 6, 2019)